UK Markets closed
NIKKEI 225
27,772.93 +305.70 (+1.11%) HANG SENG
24,952.35 +824.50 (+3.42%) CRUDE OIL
86.91 -0.05 (-0.06%) GOLD FUTURES
1,847.80 +4.60 (+0.25%) DOW
34,715.39 -313.26 (-0.89%) BTC-GBP
30,785.61 -79.13 (-0.26%)
Anavex Life Sciences Corp. (0HFR.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 03:52PM GMT
| Previous close | 13.60 |
| Open | 13.65 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 13.65 - 14.01 |
| 52-week range | 13.65 - 14.01 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 805.645M |
| Beta (5Y monthly) | 0.61 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.54 |
| Earnings date | 09 Feb 2022 - 14 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Is the Options Market Predicting a Spike in Anavex (AVXL) Stock?
Investors need to pay close attention to Anavex (AVXL) stock based on the movements in the options market lately.
- Simply Wall St.
Anavex Life Sciences Corp. (NASDAQ:AVXL): Is Breakeven Near?
With the business potentially at an important milestone, we thought we'd take a closer look at Anavex Life Sciences...
- Motley Fool
Anavex Life Sciences (AVXL) Q4 2021 Earnings Call Transcript
With us today is Dr. Christopher Missling, president and chief executive officer; and Sandra Boenisch, principal financial officer. Following management's remarks, there will be a question-and-answer session.
© 2022 Yahoo. All rights reserved.
